pubmed-article:17765765 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17765765 | lifeskim:mentions | umls-concept:C0040132 | lld:lifeskim |
pubmed-article:17765765 | lifeskim:mentions | umls-concept:C0549473 | lld:lifeskim |
pubmed-article:17765765 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
pubmed-article:17765765 | lifeskim:mentions | umls-concept:C0032744 | lld:lifeskim |
pubmed-article:17765765 | lifeskim:mentions | umls-concept:C0872172 | lld:lifeskim |
pubmed-article:17765765 | lifeskim:mentions | umls-concept:C0233929 | lld:lifeskim |
pubmed-article:17765765 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:17765765 | pubmed:dateCreated | 2007-9-3 | lld:pubmed |
pubmed-article:17765765 | pubmed:abstractText | Fluorodeoxyglucose (FDG) whole body positron emission tomography (PET) scan may show clinically occult second lesions. Such lesions in the thyroid are increasingly common. There are several recent reports of a high probability of malignancy in these lesions ranging from 14% to 63%. | lld:pubmed |
pubmed-article:17765765 | pubmed:language | eng | lld:pubmed |
pubmed-article:17765765 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17765765 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17765765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17765765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17765765 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17765765 | pubmed:month | Sep | lld:pubmed |
pubmed-article:17765765 | pubmed:issn | 0194-5998 | lld:pubmed |
pubmed-article:17765765 | pubmed:author | pubmed-author:StackBrendan... | lld:pubmed |
pubmed-article:17765765 | pubmed:author | pubmed-author:SpringPaul... | lld:pubmed |
pubmed-article:17765765 | pubmed:author | pubmed-author:WalkerRonaldR | lld:pubmed |
pubmed-article:17765765 | pubmed:author | pubmed-author:BodennerDonal... | lld:pubmed |
pubmed-article:17765765 | pubmed:author | pubmed-author:KingDeanne... | lld:pubmed |
pubmed-article:17765765 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17765765 | pubmed:volume | 137 | lld:pubmed |
pubmed-article:17765765 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17765765 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17765765 | pubmed:pagination | 400-4 | lld:pubmed |
pubmed-article:17765765 | pubmed:meshHeading | pubmed-meshheading:17765765... | lld:pubmed |
pubmed-article:17765765 | pubmed:meshHeading | pubmed-meshheading:17765765... | lld:pubmed |
pubmed-article:17765765 | pubmed:meshHeading | pubmed-meshheading:17765765... | lld:pubmed |
pubmed-article:17765765 | pubmed:meshHeading | pubmed-meshheading:17765765... | lld:pubmed |
pubmed-article:17765765 | pubmed:meshHeading | pubmed-meshheading:17765765... | lld:pubmed |
pubmed-article:17765765 | pubmed:meshHeading | pubmed-meshheading:17765765... | lld:pubmed |
pubmed-article:17765765 | pubmed:meshHeading | pubmed-meshheading:17765765... | lld:pubmed |
pubmed-article:17765765 | pubmed:meshHeading | pubmed-meshheading:17765765... | lld:pubmed |
pubmed-article:17765765 | pubmed:meshHeading | pubmed-meshheading:17765765... | lld:pubmed |
pubmed-article:17765765 | pubmed:meshHeading | pubmed-meshheading:17765765... | lld:pubmed |
pubmed-article:17765765 | pubmed:meshHeading | pubmed-meshheading:17765765... | lld:pubmed |
pubmed-article:17765765 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17765765 | pubmed:articleTitle | Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. | lld:pubmed |
pubmed-article:17765765 | pubmed:affiliation | Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. | lld:pubmed |
pubmed-article:17765765 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17765765 | lld:pubmed |